drugset / Trial / NCT04056130
A Study of Single and Multiple Ascending Doses of KBL697 in Healthy Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
The study is designed to investigate the safety and tolerability of KBL697 in healthy volunteers. KBL697 has been developed as a potential new treatment for atopic dermatitis (AD).
Timeline
- Start
- 2019-10-04
- Primary completion
- 2019-12-23
- Completion
- 2020-01-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KBL697 | Unknown | 460 mg | Oral |
| Subject | KBL697 | Unknown | 4600 mg | Oral |